It was found that the 5-year OS rate of patients with gastric cancer was 68.7% for patients classified as p53 wild-type, and 31.9% for those with the p53 mutant pattern, and there was also a significant difference in the 5-year disease-free survival rate between the two groups. This evidence concerns the gene TP53 and gastric cancer.